3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostate CA
1
Lymphoma, Follicular
1
Cognitive Dysfunction
1
Alzheimer Disease
1
Interventions
Transcranial Direct Current Stimulation
2
Exercise
2
mazdutide
1
lime
1
fasudil
1
enzalutamide
1
Time
1
Tablets
1
Standard of Care
1
Referral and Consultation
1
Ramipril
1
Radiosurgery
1
Prednisone
1
Population Groups
1
Palliative Care
1
Organization and Administration
1
Modafinil
1
Methods
1
Metformin
1
Mental Status and Dementia Tests
1
Memantine
1
Low-Level Light Therapy
1
Hormones
1
Health
1
Gonadotropin-Releasing Hormone
1
Electroencephalography
1
Drug Delivery Systems
1
Data Collection
1
Anesthesia, General
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognitive Dysfunction
×
fasudil
×
1 year
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled